Noticias Wave Life Sciences Ltd - WVE | Acciones NASDAQ | ADVFN

US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Wave Life Sciences Ltd (WVE)

9.535

-0.135

( -1.40% )

Actualizado: 07:50:58

Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Dosing underway in INLIGHT trial of WVE-007 in obesity with clinical data expected in 2H 2025; enrollment...

Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025

CAMBRIDGE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity

WVE-007 is a novel, long-acting GalNAc-siRNA targeting INHBE mRNA – a genetically validated target that...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Rendering Error

Rendering Error

TechandBio

TechandBio 6 días hace

Are these RNA editing indications even necessary with regular RNAI-SIRNA drug pipeline of 450 drugs seems like most of these editing drugs like gene editing are all flops companies not sure about RNA Editing when companies like ALNY and Novartis have the goods to make good old fashion Sirna drugs

$WVE

TechandBio

TechandBio 1 semana hace

https://fintel.io/i/m28-capital-management-lp

Top Increases This Quarter

We use the change in the portfolio allocation because this is the most meaningful metric. Changes can be due to trades or changes in share prices.

WVE / Wave Life Sciences Ltd. 5.66 70.07 68.7941 13.2486
TGTX / TG Therapeutics, Inc. 0.16 4.86 4.7756 0.6221
PRQR / ProQR Therapeutics N.V. 1.02 2.70 2.6525 0.6136
SWTX / SpringWorks Therapeutics, Inc. 0.11 3.99 3.9161 0.0293

almost 70% of M28 Capital is in WVE that is lead and advised John Maraganore, PhD. Alnylam Pharmaceuticals. Cambridge, MA. Brook ... M28 Capital Management.

$WVE

PonkenPlonken

PonkenPlonken 3 meses hace

TechandBio

TechandBio 3 meses hace

Will wait for buyout on my $6.80 average here.

$WVE

TechandBio

TechandBio 5 meses hace

RNAI stocks are going to be the biggest driver in biotech in the through 2030 WAVE and PRQR
These could be the next ALNY
450 drugs in the pipeline worldwide for RNAI drugs.

$WVE

boston127

boston127 5 meses hace

Gotta love their business.

If their RNA model works, it could have fantastic results for humanity.

PonkenPlonken

PonkenPlonken 5 meses hace

Finally,,,,,,,, "they" will water them all and things will get going. RNA in genetic diseases....

PonkenPlonken

PonkenPlonken 5 meses hace

Awl416

Awl416 5 meses hace

Wave Life Sciences Announces First-Ever Therapeutic RNA Editing in Humans Achieved in RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency

TechandBio

TechandBio 6 meses hace

WVE Can't wait for the Phase 1 Obesity indication to commence later this year or early 2025 thats the icing on the cake.

$WVE

PonkenPlonken

PonkenPlonken 6 meses hace

can you say breakout?

PonkenPlonken

PonkenPlonken 6 meses hace

why claim this afterwards? Pointless

TechandBio

TechandBio 6 meses hace

Poetry in Motion!

$WVE

TechandBio

TechandBio 6 meses hace

Solid looking for more!

Glad I doubled up last week!

$WVE

PonkenPlonken

PonkenPlonken 6 meses hace

wowser there it is

Dystrophin results from a pre-specified analysis of ambulatory boys showed:
Mean absolute muscle content-adjusted dystrophin expression was 9.0% (range: 4.6-13.9%) and mean absolute unadjusted dystrophin expression was 5.5% of normal (range: 3.3-8.3%), as measured by Western Blot.
[...]
89% of ambulatory participants achieved muscle content-adjusted dystrophin levels of at least 5%.

Monksdream

Monksdream 6 meses hace

Monksdream

Monksdream 9 meses hace

PonkenPlonken

PonkenPlonken 9 meses hace

one of the singaporean companies that does not look like a scam but rather like singaporean excellence.

Monksdream

Monksdream 11 meses hace

Monksdream

Monksdream 1 año hace

WVE new 52 week high

TrendTrade2016

TrendTrade2016 1 año hace

WVE...BEAUTIFUL WEEKLY

TrendTrade2016

TrendTrade2016 1 año hace

WVE...BIO MONSTER SETTING UP

PRIVATE SHAREHOLDER

PRIVATE SHAREHOLDER 2 años hace

Big clinical news coming shortly

PRIVATE SHAREHOLDER

PRIVATE SHAREHOLDER 2 años hace

Company reporting big news next week. Stay tuned!

MiamiGent

MiamiGent 2 años hace

WVE stretched out this morning!

WAVE LIFE SCIENCES LTD
$5.24 +$0.20 (+3.97%)

WVE is a real stock!

https://stockcharts.com/h-sc/ui?s=WVE

Wave Life Sciences

Federal Agricultural Mor...

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones